Award
Delivery Order #36C24826N0520
Thyroid Cancer Molecular Testing Delivery Order Awarded to Interpace Diagnostics
Buyer
Department of Veterans Affairs
Award Amount
$288,000.00
Ceiling
$1,524,000.00
Awarded
May 28, 2026
Period of Performance
May 28, 2026 – May 27, 2027
Identifier
36C24826N0520
NAICS
621511
This is a delivery order contract awarded to Interpace Diagnostics Corporation, a company specializing in molecular testing technologies. The contract involves procuring thyroid cancer molecular tests, critical for advancing diagnostic accuracy and patient care in oncology. It supports a larger indefinite delivery vehicle focused on thyroid cancer testing across multiple Veterans Affairs Medical Centers, including the Orlando VAMC and San Juan VAMC. Awarded on a recent date with a one-year performance period, this contract underscores the agency's commitment to innovative cancer diagnostics. The scope includes the provision and delivery of specialized molecular tests to aid in thyroid cancer diagnosis. The award followed the parent contract and was likely competitively sourced, given the structured indefinite delivery vehicle approach. The contract enhances disease detection capabilities and supports improved clinical outcomes within the veteran healthcare system.
Description
THYROID CANCER MOLECULAR TESTS